Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.

ABSTRACT:

Importance

While cervical cancer screening with cytologic and human papillomavirus (HPV) testing has reduced mortality from cervical cancer, overuse of these tests is associated with downstream psychological and medical consequences, as well as significant costs. Guidelines now recommend less frequent testing, although adherence to these recommendations is uncertain.

Objective

To determine the frequency of overuse of cervical cancer screening tests.

Design, setting, and participants

This cohort study included 2 299 177 women aged 30 to 65 years recorded in the MarketScan database who underwent cervical cancer screening with cervical cytologic testing, cotesting, or primary HPV testing in 2013 through 2014. Women were followed-up for 3 years, and use of repeat testing

SUBMITTER: Wright JD 

PROVIDER: S-EPMC8085723 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature